Mathers Edward T. - 23 Jun 2022 Form 4 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role
Director
Signature
/s/ Louis Citron, attorney-in-fact
Issuer symbol
TRVI
Transactions as of
23 Jun 2022
Net transactions value
$0
Form type
4
Filing time
23 Jun 2022, 17:04:07 UTC
Previous filing
14 Jun 2022
Next filing
15 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRVI Nonstatutory Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 23 Jun 2022 Common Stock 20,000 $2.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 23, 2022. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.